Data Analytics Engineer, Implicity

€55-60k

SQL
AWS
GCP
Python
Tableau
Looker
Postgres
Airflow
Athena
NumPy
Pandas
Scikit-Learn
Metabase
Slack
Notion
dbt
Mid and Senior level
Paris

2+ days a week in office

Implicity

Universal remote monitoring platform for cardiac patients

Be an early applicant

Implicity

Universal remote monitoring platform for cardiac patients

21-100 employees

HealthcareB2BArtificial IntelligenceDeep TechSaaSMedTech

Be an early applicant

€55-60k

SQL
AWS
GCP
Python
Tableau
Looker
Postgres
Airflow
Athena
NumPy
Pandas
Scikit-Learn
Metabase
Slack
Notion
dbt
Mid and Senior level
Paris

2+ days a week in office

21-100 employees

HealthcareB2BArtificial IntelligenceDeep TechSaaSMedTech

Company mission

To improve clinic operations and the standard of care by harnessing the full power of data.

Company mission

To improve clinic operations and the standard of care by harnessing the full power of data.

Top investors

15% employee growth in 12 months

Our take

The MedTech boom has seen many innovations through the 2010s, and Implicity, a remote patient monitoring and cardiac data management company, has definitely had a clear lineage of growth since its founding in 2016.

Implicity develops software to monitor and analyse the information from pacemakers and cardiovascular devices to aid physicians and healthcare professionals through all stages of a patient’s treatment. However, maintaining growth on one product alone is hard, especially with so much Medtech competition. Implicity remedies this with its other product, a data analysis platform that uses AI and cloud technology to analyse the devices linked up to its aforementioned pacemaker and cardio health platform. Implicity leverages this data for use in patient management, clinical studies, and R&D.

Playing both fields of MedTech has diversified the draw for hospitals and companies to Implicity. It continues to update and diversify the double offering via updates to its systems with the company hoping to exemplify the continued innovation that is key to MedTech company growth.

Freddie headshot

Freddie

Company Specialist at Welcome to the Jungle

Benefits

  • 25% variable, based on annual objectives (uncapped)
  • Eligible for the BSCPE award

Funding (last 2 of 3 rounds)

Jul 2024

$2.8m

GRANT

Apr 2022

$23m

SERIES A

Total funding: $30.1m

This company has top investors

Leadership

Arnaud Rosier

(CEO & Founder)

Currently Cardio Electrophysiologist at Ramsay Santé Hospital. Previously Cardiac Electrophysiologist at Groupement des Hôpitaux de l'Institut Catholique de Lille and Cardiologist at ADHP.

David Perlmutter

(Chief Innovation Officer & Co-Founder)

Previously R&D at AIRTAG, Project Manager at HITRONETIC and Research Intern at CNES.

Jobs (13)

All locations

Software Engineering

Finance, Legal & Compliance

Other Engineering